Leif Lee
Chief Financial Officer
Replay available
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Chief Financial Officer
Chief Executive Officer
Analyst, Leidenberg Securities
Analyst, Mizuho Securities
Analyst, Cantor Fitzgerald
Analyst, Oppenheimer & Co.
Analyst, Jefferies
Analyst, H.C. Wainwright & Co.
Watch the replay and follow the connected company analysis, news, and investor updates for Corvus Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.318 everyone. Thank you for standing by and welcome to the Corvus Pharmaceuticals 00:00:05.318 -- 00:00:07.721 first quarter 2025 00:00:07.721 -- 00:00:12.107 business update and financial results conference call. 00:00:12.107 -- 00:00:16.172 At this time, all participants are in a listen-only mode. 00:00:16.172 -- 00:00:21.198 Later, we will conduct a question and answer session and instructions will follow at 00:00:21.198 -- 00:00:26.305 that time. It is now my pleasure to turn the call over to Zach Kubo of 00:00:26.305 -- 00:00:30.408 Real Chemistry. Please go ahead, sir. 00:00:30.878 -- 00:00:34.463 Thank you, Operator, and good afternoon, everyone. 00:00:34.463 -- 00:00:39.770 Thanks for joining us today on the call. This conference call is being webcast with presentation 00:00:39.770 -- 00:00:44.977 slides. We encourage participants to join the webcast in order to view the slides. 00:00:44.977 -- 00:00:49.624 You can find the link to join the webcast on the Investor Relations homepage of the Corvus 00:00:49.624 -- 00:00:51.624 website. 00:00:52.147 -- 00:00:56.092 Turning to slide two, I would like to remind everyone that comments made by management 00:00:56.092 -- 00:01:00.292 today and answers to questions will include forward-looking statements. 00:01:00.292 -- 00:01:04.338 Forward-looking statements are based on estimates and assumptions as of today and are 00:01:04.338 -- 00:01:08.804 subject to risks and uncertainties that may cause actual results to differ materially 00:01:08.804 -- 00:01:13.010 from those expressed or implied by those statements, including the risks and uncertainties 00:01:13.010 -- 00:01:18.899 described in Corvus' quarterly report on Form 10-Q for the quarter ended March 31, 2025, 00:01:18.899 -- 00:01:...